The health insurer Cigna Group snatched away a lifeline from Humana on Monday morning, telling investors it has no intention ...

Wells Fargo analyst Steve Baxter maintained a Buy rating on Humana (HUM – Research Report) today and set a price target of $315.00. The ...

Company officials said Monday they are not pursuing a merger with rival Humana, causing Cigna's stock to rise in the markets.

Shares of Humana (NYSE:HUM) slid 7% premarket on Monday after Cigna (NYSE:CI) confirmed it won’t pursue combination with the ...

Since the start of the year, Humana stock is underperforming with a 39.4% deficit. The $300 level, which provided support ...

Despite reports that merger talks were back on, Cigna officially squashed rumors that it was looking to acquire Humana in a ...

Cigna's bold move to halt merger talks with Humana sends shockwaves through the market, while stock buybacks ramp up.

BofA Securities has recently raised Humana Inc (HUM) stock to Neutral rating, as announced on November 6, 2024, according to Finviz. Earlier, on October 11, 2024, KeyBanc Capital Markets had initiated ...

On Monday, Humana Inc (HUM) stock saw a decline, ending the day at $282.44 which represents a decrease of $-5.68 or -1.97% from the prior close of $288.12. The stock opened at $273 and touched a low ...

Humana (HUM) shares are falling 5% in premarket trading Monday after The Cigna Group (CI) said it is not pursuing a combination with its smaller health insurance rival. Cigna stock, meanwhile ...

On Monday, Cigna Group (NYSE:CI) said its officials are expected to participate in meetings with investors and analysts over ...